Nemucore Medical Innovations

Location:MA, US
Speaker:Timothy Coleman
Title:Ph.D.
Primary Industry:Pharma & Biotech
Executive Summary:Nemucore Medical Innovations utilizes proprietary nanoformulation technology to develop generational improvements to widely used drugs and facilitate delivery of poorly soluble drugs. Nemucore is dedicated to the improvement of human therapy. Our mission is to innovate, develop, produce and sell efficacious nano-biopharmaceuticals within indications where our products can be considered a primary therapeutic alternative. Nemucore was founded by a team of highly experienced, successful serial entrepreneurs in the pharmaceutical and biotechnology industries and brings the highest level of scientific expertise in nanomedicine, drug development, and oncology. Our in vitro and in vivo data indicate that generic drugs can be delivered with improved clinical characteristics. Spontaneous Self Assembling Nanoparticles (SSANs) have utility across many indications. By developing this technology, we believe we can move an oncology compound to clinical trials during the next 24 months. In addition, we are proceeding with a two-pronged approach to provide a balanced and robust business platform; creating significant shareholder value. In addition to reformulation of existing oncology drugs (generics) we plan to partner in other indications such as poorly soluble drugs and drugs close to patent expiration.
Venture is:Seed Level

HIGHLIGHTS

Merck
Corporate Symposium

Harvard OTD
Partner Sponsor

2008 Corporate Presentations

Air Products
Boeing
BP
Cabot
Honda
Kodak
Medtronic
Merck
  • BASF
  • Genzyme
  • Lockheed Martin
  • Sanyo

Event Sponsors

Univalor
AzTE
Jackson Walker

Collocated Events

June 1-5, 2008
Nanotech 2008
Clean Technology 2008
BioNano 2008

Press Sponsor

Business Wire

Commercialization Partner

BusinessWeek

Media Sponsors

(joint with Nanotech 2008) Nature
Science
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network
piribo

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect